{
    "2018-11-22": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Pfizer's FDA Nod for Cancer Drug is Four in a Row in 90 Days",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "FDA",
                        "Cancer Drug",
                        "Four in a Row",
                        "90 Days"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Pfizer Stock Has Multiple Positive Catalysts",
                "features": {
                    "keywords": [
                        "Pfizer Stock",
                        "Positive Catalysts"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}